ENDRA Life Sciences 13G Filing Shows S.H.N. Financial Investments Ltd. Reported A 9.99% Stake In The Co As Of June 4, 2024
Portfolio Pulse from Benzinga Newsdesk
ENDRA Life Sciences' recent 13G filing reveals that S.H.N. Financial Investments Ltd. has acquired a 9.99% stake in the company as of June 4, 2024.
June 14, 2024 | 8:07 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
S.H.N. Financial Investments Ltd. has reported a 9.99% stake in ENDRA Life Sciences as of June 4, 2024, according to a recent 13G filing.
The acquisition of a significant stake by S.H.N. Financial Investments Ltd. is a positive signal for ENDRA Life Sciences, indicating confidence from a major investor. This could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100